CompletedN/AOther

Characterization of the Prosocial and Prosexual Effects of GHB

Sponsored by University of Zurich

NCT ID
NCT02342366
Target Enrollment
19 participants
Start Date
2012-02
Est. Completion
2014-12

About This Study

The purpose of this study is to determine whether gamma-Hydroxybutyrate (GHB) has prosocial and prosexual effects in healthy male participants, and to characterize these putative effects via behavioral tests, functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and neuroendocrine parameters. The investigators predict that GHB in fact has prosocial and prosexual effects which can be neurobiologically characterized using the assessed methods. Such effects would be of high interest for the treatment of mental disorders which involve impairments of social interaction and sexual function such as major depression or autism.

Conditions Studied

Depressive Disorder, MajorBipolar DisorderAutistic Disorder

Interventions

  • GHB 35 mg/kg p.o.
  • GHB 20 mg/kg p.o.

Eligibility

Sex:MALE
Age:18 Years - 40 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Healthy male subjects.

Exclusion Criteria:

* Any Axis-I DSM-IV psychiatric disorder, any form of addiction or regular illegal drug use (lifetime use \>5 occasions) with exception of occasional cannabis use, a lifetime history of GHB use, a neurological disorder or head injury, clinically relevant medical diseases, a family history of schizophrenia or bipolar disorder, and any use of prescription drugs.

Study Locations (1)

Hospital for Psychiatry, University of Zurich
Zurich, Switzerland

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Characterization of the Prosocial and Prosexual Effects of GHB | Huxley